Pharmacontrol L L C Estn is categorized under Research and Development Laboratories in Palo Alto, CA and active since 2005.
Pharmacontrol L L C Estn was established in 2005, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Thomas Mullan at the company’s single location by writing to 366 South California Avenue, Palo Alto, California CA 94306 or by phoning (650) 322-2218. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pharmacontrol L L C Estn |
Contact Person: | Thomas Mullan |
Address: | 366 South California Avenue, Palo Alto, California 94306 |
Phone Number: | (650) 322-2218 |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Pharmacontrol L L C Estn was started in 2005 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Thomas Mullan for inquiries that concern Pharmacontrol L L C Estn by calling the company number (650) 322-2218, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmacontrol L L C Estn can be found at the coordinates 37.426944,-122.144536 as well as the street address 366 South California Avenue in Palo Alto, California 94306.
For its online presence, you may visit Pharmacontrol L L C Estn’s website at and engage with its social media outlets through on Twitter and on Facebook.